Abstract
Genome wide association studies have identified several genes that might be associated with increase susceptibility to Type 1 Diabetes (T1D) and Crohn's disease. Both Crohn's disease and T1D have a profound impact on the lives of patients and it is pivotal to investigate the genetic role in patients acquiring these diseases. Understanding the effect of single nucleotide polymorphisms (SNP's) in key genes in patients suffering from T1D and Crohn's disease is crucial to finding an effective treatment and generating novel therapeutic drugs. This review article is focused on the impact of SNP's in PTPN2 (protein tyrosine phosphatase, non-receptor type 2) and PTPN22 (protein tyrosine phosphatase non-receptor type 22) on the development of Crohn's disease and T1D. The PTPN2 gene mutation in T1D patients play a direct role in the destruction of beta cells while in Crohn's disease patients, it modulates the innate immune responses. The PTPN22 gene mutations also play a role in both diseases by modulating intracellular signaling. Examining the mechanism through which these genes increase the susceptibility to both diseases and gaining a better understanding of their structure and function is of vital importance to understand the etiology and pathogenesis of Type 1 Diabetes and Crohn's disease.
Highlights
Type 1 DiabetesType 1 Diabetes (T1D) is a chronic metabolic disorder that accounts for 5–10% of all diabetic cases
Regardless of the etiological factors of T1D, it is well-accepted that the destruction of pancreatic beta cells affects the level of insulin secretion leading to disease development
The PTPN2 gene mutation in T1D patients plays a direct role in the destruction of beta cells, while in Crohn’s disease patients, it modulates the innate immune responses (Barrett et al, 2008; Espino-Paisan et al, 2011)
Summary
Type 1 Diabetes (T1D) is a chronic metabolic disorder that accounts for 5–10% of all diabetic cases. GWAS have shown that several candidate genes may cause an increase in the susceptibility to developing Crohn’s disease (Barrett et al, 2008). These genes include: NOD2, ATG16L1, IL23R, IRGM, CCR6, PTPN2, and PTPN22 (Figure 2; Barrett et al, 2008). The PTPN2 gene mutation in T1D patients plays a direct role in the destruction of beta cells, while in Crohn’s disease patients, it modulates the innate immune responses (Barrett et al, 2008; Espino-Paisan et al, 2011). Chromosome loci 18p11 Two major alternative splicing Endosplasmic reticulum and nucleus Variable
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
